日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Blockchain integration in healthcare: a comprehensive investigation of use cases, performance issues, and mitigation strategies

区块链在医疗保健领域的应用:用例、性能问题及缓解策略的全面调查

Kasyapa, Meenavolu S B; Vanmathi, C

Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells

靶向抑制去泛素化酶USP14和UCHL5可诱导华氏巨球蛋白血症肿瘤细胞发生蛋白毒性应激和凋亡。

Chitta, Kasyapa; Paulus, Aneel; Akhtar, Sharoon; Blake, Maja Kristin K; Caulfield, Thomas R; Novak, Anne J; Ansell, Stephen M; Advani, Pooja; Ailawadhi, Sikander; Sher, Taimur; Linder, Stig; Chanan-Khan, Asher

Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15

蛋白酶体去泛素化酶抑制剂b-AP15衍生物的合成及评价

Xin Wang, Pádraig D'Arcy, Thomas R Caulfield, Aneel Paulus, Kasyapa Chitta, Chitralekha Mohanty, Joachim Gullbo, Asher Chanan-Khan, Stig Linder

Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications

Waldenström巨球蛋白血症细胞系的免疫表型分析揭示了不同的表面抗原表达模式:潜在的生物学和治疗意义

Aneel Paulus ,Kasyapa S Chitta ,Paul K Wallace ,Pooja P Advani ,Sharoon Akhtar ,Maja Kuranz-Blake ,Sikander Ailawadhi ,Asher A Chanan-Khan

AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia

AT-101 下调 BCL2 和 MCL1,并增强来那度胺和地塞米松在多发性骨髓瘤和瓦尔登斯特伦巨球蛋白血症临床前模型中的细胞毒性作用

Aneel Paulus #, Kasyapa Chitta #, Sharoon Akhtar, David Personett, Kena C Miller, Kevin J Thompson, Jennifer Carr, Shaji Kumar, Vivek Roy, Stephen M Ansell, Joseph R Mikhael, Angela Dispenzieri, Craig B Reeder, Candido E Rivera, James Foran, Asher Chanan-Khan

Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1

新型人华氏巨球蛋白血症细胞系的建立和表征:RPCI-WM1,罗斯威尔帕克癌症研究所 - 华氏巨球蛋白血症 1

Chitta, Kasyapa S; Paulus, Aneel; Ailawadhi, Sikander; Foster, Barbara A; Moser, Michael T; Starostik, Petr; Masood, Aisha; Sher, Taimur; Miller, Kena C; Iancu, Dan M; Conroy, Jeffrey; Nowak, Norma J; Sait, Sheila N; Personett, David A; Coleman, Morton; Furman, Richard R; Martin, Peter; Ansell, Stephen M; Lee, Kelvin; Chanan-Khan, Asher A

Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response

来那度胺诱导慢性淋巴细胞白血病患者肿瘤爆发反应的生物学效应和临床意义:体内免疫激活和抗肿瘤反应的证据

Chanan-Khan, Asher A; Chitta, Kasyapa; Ersing, Noreen; Paulus, Aneel; Masood, Aisha; Sher, Taimur; Swaika, Abhisek; Wallace, Paul K; Mashtare, Terry L Jr; Wilding, Greg; Lee, Kelvin; Czuczman, Myron S; Borrello, Ivan; Bangia, Naveen

Targeted treatment for chronic lymphocytic leukemia

慢性淋巴细胞白血病的靶向治疗

Masood, Aisha; Sher, Taimur; Paulus, Aneel; Miller, Kena C; Chitta, Kasyapa S; Chanan-Khan, Asher

Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression

前列腺来源的Ets因子的表达特征支持其在乳腺癌和前列腺癌进展中的作用。

Sood, Ashwani K; Saxena, Rakhee; Groth, Jeff; Desouki, Mohamed M; Cheewakriangkrai, Chalong; Rodabaugh, Kerry J; Kasyapa, Chitta S; Geradts, Joseph

Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease

在表达参与非典型骨髓增生性疾病的 ZNF198/FGFR1 融合激酶的细胞中诱导纤溶酶原激活物抑制剂-2 的表达

Kasyapa, Chitta S; Kunapuli, Padmaja; Hawthorn, Lesleyann; Cowell, John K